Search company, investor...
Tactile Medical company logo

Tactile Medical

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price




About Tactile Medical

Tactile Systems Technology manufactures and markets the Flexitouch Lymphedema System which aims to provide home therapy to help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment.

Headquarters Location

3701 Wayzata Blvd Suite 300

Minneapolis, Minnesota, 55416,

United States


Missing: Tactile Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Tactile Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Tactile Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tactile Medical is included in 2 Expert Collections, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Tactile Medical Patents

Tactile Medical has filed 37 patents.

The 3 most popular patent topics include:

  • Hosiery
  • Sports clothing
  • Syndromes
patents chart

Application Date

Grant Date


Related Topics




Vascular diseases, Syndromes, Rare diseases, Hematology, Vascular-related cutaneous conditions


Application Date


Grant Date



Related Topics

Vascular diseases, Syndromes, Rare diseases, Hematology, Vascular-related cutaneous conditions



Latest Tactile Medical News

Tactile Medical Appoints Carmen Volkart to Board of Directors

Jan 5, 2023

Minneapolis, Minnesota, UNITED STATES MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company’s Board of Directors (“Board”), effective January 5, 2023. “Carmen joins our Board with more than 40 years of experience in financial and managerial positions, including extensive experience leading medical device companies,” said Bill Burke, Chairman of the Board of Tactile Medical. “We are glad to welcome Carmen to Tactile Medical and look forward to benefiting from her operating expertise and strategic insight.” Since 2018, Carmen Volkart has served as the Chief Financial Officer of NatureWorks LLC, a privately-held advanced materials company and developer of renewably sourced polymers and chemicals. Prior to joining NatureWorks, she served as the Chief Financial Officer of NxThera, Inc., a privately-held medical device company focused on the treatment of benign prostatic hyperplasia, from 2012 until its acquisition by Boston Scientific in 2018. From 2010 to 2012, Ms. Volkart served as Chief Financial Officer of Tornier, N.V., a medical device company focused on treating musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. She led Tornier through a successful initial public offering in 2011. Prior to joining Tornier, Ms. Volkart served as Chief Operating and Financial Officer, Corporate Secretary, Compliance Officer and Treasurer of Spine Wave, Inc., a privately-held medical device company focused on minimally invasive spine surgery and expandable interbody devices, from 2006 to 2010. From 2004 to 2006, Ms. Volkart served as Executive Vice President, and Chief Financial Officer of American Medical Systems, Inc., a publicly traded medical device company focused on male and female pelvic health. Her career history also includes significant experience in various financial and managerial positions at both Medtronic, Inc., from 1992 to 2004, and Honeywell, Inc., from 1982 to 1992. About Tactile Medical Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Tactile Medical Frequently Asked Questions (FAQ)

  • When was Tactile Medical founded?

    Tactile Medical was founded in 1995.

  • Where is Tactile Medical's headquarters?

    Tactile Medical's headquarters is located at 3701 Wayzata Blvd, Minneapolis.

  • What is Tactile Medical's latest funding round?

    Tactile Medical's latest funding round is IPO.

  • How much did Tactile Medical raise?

    Tactile Medical raised a total of $28.87M.

  • Who are the investors of Tactile Medical?

    Investors of Tactile Medical include Galen Partners, Radius Ventures, Cedar Point Capital, Sofia Fund, St. Cloud RAIN Fund and 5 more.

  • Who are Tactile Medical's competitors?

    Competitors of Tactile Medical include Acelity, Light Sciences Oncology, Augmenix, Catheter Connections, Pathfinder Therapeutics and 10 more.

Compare Tactile Medical to Competitors

eNeura Therapeutics

eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.

Mercator MedSystems

Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.

AlterG Logo

AlterG builds technology for physical rehabilitation, training and wellness with the goal of enabling people to sustain healthy and active lives through mobility. The company's products, the Anti-Gravity Treadmills and the AlterG Bionic Leg, are designed to enhance personal mobility and wellness. Its Anti-Gravity Treadmills use Differential Air Pressure (DAP) technology, originally developed at NASA, to unweight patients to as low as 20% of their body weight, enabling them to walk or run with reduced impact. The Bionic Leg, designed for patients with neurological and orthopedic gait disorders, is a robotic assistive device that is activated by patient initiated movement and provides stability and assistance for a full range of mobility training.


CardioOptics is a developer of Trans-Blood Vision products to provide catheter-based direct visualization through blood using infrared light.

CivaTech Oncology Logo
CivaTech Oncology

Civatech Oncology is a medical device company focused on the development of polymer based devices that treat cancer using localized, low-dose-rate radiation. The company's fabrication methods allow for precise encapsulation of radioactive materials into polymer structures. These polymer-based brachytherapy devices offer physicians treatment options for tumors with low-dose-rate brachytherapy.

Xoft Microtube

Xoft is engaged in the practice of radiation oncology through electronic brachytherapy with its miniaturized x-ray tube technology. It's first product, the Axxent Electronic Brachytherapy System applies radiation directly to a tumor bed within the body without the use of radioactive isotopes, heavy shielding, or major capital equipment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.